
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
MolMed S.p.A. is a clinical stage biotech company focused on research, development, manufacturing and clinical validation of innovative therapies. MolMeds product portfolio includes proprietary anti-tumor therapies in both clinical and preclinical development, both autologous and allogeneic. Zalmoxis (TK) is a cell therapy based on donor T cells genetically engineered to enable bone marrow transplants from partially compatible donors for patients with high-risk hematological malignancies, eliminating post-transplant immunosuppression prophylaxis and inducing a rapid immune reconstitution. Zalmoxis, that received orphan drug designation, is currently in Phase III, but has already obtained a Conditional Marketing Authorization by the EU Commission in the 2nd...
Cell & gene therapies,gmp cell & gene manufacturing,and car-t cells
Molmed now part of agc biologics operates in the Biotechnology research industry.
Molmed now part of agc biologics's HQ phone number is +1 617-455-4188
Molmed now part of agc biologics's revenue is 11m - 100m
Molmed now part of agc biologics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.